Stella Diagnostics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Revenue	-	-	0	0.24	0.21
Revenue Growth (YoY)	-	-	-98.13%	16.21%	-
Cost of Revenue	0.01	-	-	0.1	0.01
Gross Profit	-0.01	-	0	0.14	0.19
Selling, General & Admin	0.25	0.52	0.97	1.11	0.62
Other Operating Expenses	-	-	0	0.01	0.01
Operating Expenses	0.25	0.57	1.02	1.29	0.72
Operating Income	-0.26	-0.57	-1.02	-1.14	-0.52
Other Non Operating Income (Expenses)	-0	-	-	-	-
EBT Excluding Unusual Items	-0.26	-0.57	-1.02	-1.14	-0.52
Gain (Loss) on Sale of Investments	-	-	-	-	0
Other Unusual Items	-	-0.2	0.74	-	-
Pretax Income	-0.26	-0.77	-0.28	-1.14	-0.52
Net Income	-0.26	-0.77	-0.28	-1.14	-0.52
Net Income to Common	-0.26	-0.77	-0.28	-1.14	-0.52
Shares Outstanding (Basic)	0	-	-	-	-
Shares Outstanding (Diluted)	0	-	-	-	-
EPS (Basic)	-7.53	-	-	-	-
EPS (Diluted)	-7.53	-	-	-	-
Free Cash Flow	0	-0.33	-0.52	-0.01	-0.07
Free Cash Flow Per Share	0.01	-	-	-	-
Gross Margin	-	-	100.00%	59.87%	93.48%
Operating Margin	-	-	-22599.07%	-474.40%	-252.89%
Profit Margin	-	-	-6198.84%	-474.40%	-252.54%
Free Cash Flow Margin	-	-	-11550.67%	-2.44%	-32.87%
EBITDA	-	-0.52	-0.97	-1.08	-0.44
EBITDA Margin	-	-	-	-	-210.87%
D&A For EBITDA	-	0.05	0.05	0.06	0.09
EBIT	-0.26	-0.57	-1.02	-1.14	-0.52
EBIT Margin	-	-	-	-	-252.89%
Revenue as Reported	-	-	0	0.24	-
Advertising Expenses	0.01	0.14	0	0	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.